'Abysmal': Canadian COVID vaccine maker slams feds on lack of support - BNN | Canada News Media
Connect with us

Business

'Abysmal': Canadian COVID vaccine maker slams feds on lack of support – BNN

Published

 on


The chief executive of a Canadian biotechnology firm that specializes in messenger RNA (mRNA) vaccines is slamming the federal government’s performance on the domestic COVID-19 vaccine front.

“The Canadian government has been abysmal on this file. They’ve done the absolute minimum possible to support Providence and other Canadian biotech,” said Brad Sorenson, president and CEO of Providence Therapeutics, in an interview Monday.

“They’ve sent hundreds of millions of dollars to foreign pharmaceutical companies trying to get them to set up branch plants in Canada and have overpaid significantly for vaccines. We could’ve been supplying vaccines to the world and we could’ve been adding to the solution as opposed to driving up prices and adding to the problem,” he said.

His comments come on the same day that Providence Therapeutics announced a licensing deal for the rights to its mRNA COVID-19 vaccine with Chinese biopharma firm Everest Medicines Ltd.

Everest will pay Providence US$100 million in cash for access to the mRNA technology.

The terms of the deal also include up to US$100 million in profit sharing and up to an additional US$300 million in stock if Everest develops other products using the mRNA platform.

Sorenson blasted the federal government for what he described as a lack of support in the crucial initial months of the pandemic to develop COVID vaccines domestically, and said instead, the feds allowed billions of dollars to flow out of the country to foreign vaccine makers. 

“In March of 2020, we were one month behind Moderna,” he said. “Moderna received a billion dollars in support from Warp Speed and you can see where they’re at now. Providence received no support from the Canadian government until almost a year later and even then, we received $10 million which is nominal at best.”

Operation Warp Speed was a program launched by the former Trump administration in May last year to fund American biotech firms with the aim of developing a COVID vaccine as quickly as possible.

Spokespeople from the health, procurement and finance ministries were not immediately available for comment.

Providence’s vaccine is currently in Phase 2 trials. The company expects to enter Phase 3 trials and seek authorization by the end of the first quarter or early second quarter next year, if there are no delays along the way.

Sorenson said his company’s deal with Everest is a vote of confidence in its mRNA technology.

“Our vaccine stacks up extraordinarily well against our peers in the class of mRNA vaccines,” he said. “And now we’re seeing commercial validation as other countries and other companies see the results – they’re stepping up and they’re doing something about it.”

He said Providence has the infrastructure in place to begin ramping up manufacturing in Canada, despite the lack of domestic support.

“There’s no excuse for what the Canadian government did. They completely dropped the ball. It’s just inexcusable,” he said.

Adblock test (Why?)



Source link

Continue Reading

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version